Pulmonx Ownership | Who Owns Pulmonx?
Pulmonx Ownership Summary
Pulmonx is owned by 7.59% institutional investors, 10.76% insiders, and 81.66% retail investors. Primecap management co/ca/ is the largest institutional shareholder, holding 11.55% of LUNG shares. PRIMECAP Odyssey Aggressive Growth is the top mutual fund, with 8.73% of its assets in Pulmonx shares.
LUNG Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Pulmonx | 7.59% | 10.76% | 81.66% |
| Sector | Healthcare Stocks | 232.01% | 10.74% | -142.75% |
| Industry | Medical Device Stocks | 37.54% | 10.61% | 51.85% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Primecap management co/ca/ | 4.73M | 11.55% | $10.45M |
| Morgan stanley | 4.16M | 10.16% | $9.19M |
| Blackrock | 2.67M | 6.90% | $16.91M |
| Blackrock funding, inc. /de | 2.71M | 6.61% | $5.98M |
| Vanguard group | 2.54M | 6.21% | $5.61M |
| Fmr | 2.17M | 5.41% | $3.52M |
| Soleus capital management | 2.04M | 4.98% | $4.50M |
| Silvercrest asset management group | 1.26M | 3.15% | $2.05M |
| Deutsche bank ag\ | 1.13M | 2.75% | $2.49M |
| Kent lake pr | 926.16K | 2.30% | $1.50M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Kent lake capital | 328.29K | 0.94% | $2.08M |
| Stonepine capital management | 670.00K | 0.88% | $1.09M |
| Kent lake pr | 926.16K | 0.76% | $1.50M |
| Soleus capital management | 2.04M | 0.17% | $4.50M |
| Nano cap new millennium growth fund l p | 85.00K | 0.16% | $187.85M |
| Perkins capital management | 49.00K | 0.09% | $108.29K |
| Parkman healthcare partners | 500.66K | 0.08% | $811.07K |
| Cfm wealth partners | 264.04K | 0.08% | $583.53K |
| Gsa capital partners llp | 403.76K | 0.08% | $892.00K |
| Vestal point capital, lp | 830.00K | 0.06% | $1.34M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Soleus capital management | 2.04M | 0.17% | 2.04M |
| Kent lake pr | 926.16K | 0.76% | 926.16K |
| Vestal point capital, lp | 830.00K | 0.06% | 830.00K |
| Morgan stanley | 4.16M | 0.00% | 539.79K |
| Stonepine capital management | 670.00K | 0.88% | 524.10K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Fmr | 2.17M | 0.00% | -2.09M |
| Deerfield management company, l.p. (series c) | - | - | -1.89M |
| Bnp paribas asset management | - | - | -1.17M |
| Victory capital management | - | - | -834.30K |
| Altium capital management lp | - | - | -815.00K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Soleus capital management | 2.04M | 0.17% | 2.04M | $4.50M |
| Kent lake pr | 926.16K | 0.76% | 926.16K | $1.50M |
| Vestal point capital, lp | 830.00K | 0.06% | 830.00K | $1.34M |
| Kent lake capital | 328.29K | 0.94% | 328.29K | $2.08M |
| Westfield capital management co lp | 184.90K | 0.00% | 184.90K | $408.64K |
Sold Out
| Holder | Change |
|---|---|
| Clearstead advisors | -1.00 |
| Nelson, van denburg & campbell wealth management group | -7.00 |
| Bryn mawr trust | -8.00 |
| True wealth design | -9.00 |
| Quadrant capital group | -11.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 20 | -81.31% | 3,105,451 | -90.25% | 7 | 0.12% | 9 | -83.33% | 6 | -80.00% |
| Sep 30, 2025 | 28 | -75.22% | 4,194,703 | -88.43% | 10 | 0.13% | 12 | -79.66% | 7 | -79.41% |
| Jun 30, 2025 | 113 | -5.83% | 36,256,146 | 0.28% | 90 | 1.10% | 58 | 3.57% | 34 | 6.25% |
| Mar 31, 2025 | 9 | -92.62% | 3,281,067 | -90.85% | 8 | 0.10% | 4 | -93.44% | - | -100.00% |
| Dec 31, 2024 | 122 | 5.17% | 35,871,067 | 1.30% | 91 | 1.12% | 61 | -7.58% | 32 | 14.29% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| PRIMECAP Odyssey Aggressive Growth | 3.60M | 8.73% | -32.40K |
| Fidelity Small Cap Growth | 1.49M | 3.67% | - |
| Vanguard US Total Market Shares ETF | 1.16M | 2.92% | - |
| Vanguard Total Stock Mkt Idx Inv | 1.15M | 2.79% | - |
| Fidelity Select Pharmaceuticals Port | 958.75K | 2.35% | - |
| iShares Russell 2000 ETF | 890.38K | 2.16% | 158.73K |
| Xtrackers S&P 500 Swap ETF 1C | 692.75K | 1.68% | -5.11K |
| Strategic Advisers Fidelity US TtlStk | 660.30K | 1.64% | - |
| Vanguard US Opportunities Ins USD Acc | 666.79K | 1.62% | - |
| Fidelity Advisor Small Cap I | 628.39K | 1.54% | -190.41K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Mar 02, 2026 | Radhakrishnan Srikanth | Chief Science &Techn. Officer | Sell | $6.00K |
| Mar 02, 2026 | Radhakrishnan Srikanth | Chief Science &Techn. Officer | Sell | $1.08K |
| Mar 02, 2026 | Radhakrishnan Srikanth | Chief Science &Techn. Officer | Sell | $3.52K |
| Mar 02, 2026 | Radhakrishnan Srikanth | Chief Science &Techn. Officer | Sell | $4.39K |
| Mar 02, 2026 | French Glendon E. III | President and CEO | Sell | $3.87K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | 15 |
| 2025 Q4 | - | 11 |
| 2025 Q3 | - | 12 |
| 2025 Q2 | 1 | 15 |
| 2025 Q1 | - | 16 |
LUNG Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools